Richard is the Head of Analytical Chemistry at The Centre for Drug Research and Development (CDRD). With over 15 years of drug development experience (formerly at Angiotech Pharmaceuticals), Richard has developed intellectual property in diverse technology areas with over 70 patents and applications filed in 12 patent families (5 issued). He has completed formulation development for multiple pre-clinical & clinical stage drugs & medical devices.

Dominic is the Director, Technology & Venture Development at MaRS Innovation. He holds a PhD (Biological Chemistry) from University of Toronto and an MBA from the Rotman School of Management, at the University of Toronto. He has over 10 years experience in biotech and finance, including venture capital, business development and R&D. Dominic was previously a director at BDC Venture Capital and a scientist at Diversa Corporation.

Jon is Sr. Director, Business Development at CDRD, and was previously at QLT Inc and Eli Lilly, with responsibilities for new product planning, market research and licensing activities. Jon also had research roles at Indiana University and Genetic Therapy Inc. He received a BS Biology and MBA from Indiana University and his MS Biotechnology from Johns Hopkins University.

Michael is a Professor in the School of Kinesiology & Health Science at York University and a Sr. Scientist at LMC Diabetes & Endocrinology, with a PhD in Medical Sciences from McMaster University. Researching hormonal responses to exercise and stress in diabetes, Michael is an expert on exercise and hypoglycemia prevention in type 1 diabetes, and a contributing author to multiple Canadian and international clinical practice guidelines.